Merck naming troubles continue

Share this article:

Same-name problems continue to plague US-based and Germany-based Mercks. Bloomberg reports that while confusion has been an ongoing concern since the companies split in the early 20th century, a recent protest by the StopAIDS group is further proof that a different home base is not enough for activists to go on.

The latest problem is that activists protested the German Merck, known as Merck KGaA, in front of which they pitched a complaint against its move to block low-cost copies of patented drugs from flowing into South Africa, but the company that is actually involved is the Merck which has headquarters in New Jersey.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.